About Danmar Capital
Danmar Capital is a venture capital firm As of Oct 2017, Danmar Capital has invested in 2 companies. It primarily invests in Series B round in United States based startups. Its investments are spread across a wide range of sectors from Enterprise Applications to Life Sciences and High Tech. Most recently it participated in the $***** Series B round of LISNR Overall, Danmar Capital portfolio has seen 1 acquisition, namely Assurex Health. A lot of funds co-invest with Danmar Capital, with names like Synchrony sharing a substantial percentage of its portfolio.Key Metrics
Portfolio Count
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Series B & Series D
Portfolio Acquisitions
Danmar Capital's List of All Investments
Danmar Capital has a portfolio of 2 companies. Their most notable investments are in LISNR and Assurex Health.Their portfolio spans across and United States. They have invested in Enterprise Applications, Life Sciences, High Tech and 2 other sectors, across stages such as Series B, Series D stages. Here is the list of all investments by Danmar Capital:
1. LISNR
LISNR provides an ultrasonic data-over-sound technology. Offers an ultrasonic proximity platform that is used to transmit micro-communications & information between devices using sound between devices on standard speakers and microphones. Offers LISNR Point for 1:1 ultrasonic data transfer & authentication (SDK) between devices to facilitate a contactless transaction between a client && host device within ~1ft & under, LISNR Zone for data transfer & authentication featuring concurrent transmissions, LISNR Radius for long range ultrasonic data transfer (SDK) between devices greater than 10ft and Acceptance Device for transmission leveraging multiple speakers & microphone for performance. Is available in a subscription-based pricing model. Clients include AT&T, Ticketmaster, Land Rover, Heineken, Live Nation, and more.
Key facts about LISNR
- Founded Year: 2012
- Location: Cincinnati (United States)
- Stage: Series C
- Total Funding till date: $16.4M
- Employee Count: 36 as on Jul 01, 2024
- Investors: Mastercard, Singularity Investments and 32 Others
- Latest Funding Round: Series C, Mar 2022, $*****
- Highlight: Editors' Pick
Assurex Health is a personalized medicine company dedicated to helping clinicians determine the right medication for individual patients suffering from neuropsychiatric and other medical conditions. Assurex Health’s proprietary Genesight technology is based on pharmacogenomics – the study of the genetic factors that influence an individual’s response to drug treatments – as well as evidence-based medicine and clinical pharmacology.
Key facts about Assurex Health
- Founded Year: 2006
- Location: Mason (United States)
- Stage: Acquired
- Total Funding till date: $84.5M
- Employee Count: 390 as on Dec 31, 2022
- Investors: Cross Creek, Claremont Creek Ventures and 16 Others
- Latest Funding Round: Series D, Dec 21, 2015, $*****
- Highlight: Acquired
Danmar Capital's Year-on-Year Investment Trends
Danmar Capital has invested in LISNR in 2017 and Assurex Health in 2014. Its most recent first time investment was in LISNR.Danmar Capital's Investments by Stage
Danmar Capital has made 1 investment in Series B stage and 1 investment in Series D stage with an average round size of $37.4M.Danmar Capital's Investments by Sector
Danmar Capital has a diverse portfolio, with companies operating in the Enterprise Applications, High Tech, Consumer, HealthTech and Life Sciences. Notably, it has invested in 2 Enterprise (B2B) companies, 2 Software companies, 2 Tech companies and 1 company focusing on Saas.Sector | No. of Investments |
|---|---|
Enterprise Applications | 2 |
High Tech | 2 |
Consumer | 1 |
HealthTech | 1 |
Life Sciences | 1 |
Note: We have considered here, only first round of investments
Danmar Capital's Investments by Geography
Danmar Capital has made most investments in United States (2).Danmar Capital's recent investments
Danmar Capital has not made any investment in 2026 so far.Here are the most recent investments by Danmar Capital:
Filter this listDate | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Oct 25, 2017 | United States | Series B | 2971 | [+4] | |
Dec 23, 2014 | United States | Series D | 5063 | [+7] |
Acquired companies in Danmar Capital's Portfolio
1 company from Danmar Capital's portfolio has been acquired. The most recent acquisition was Assurex Health in Aug 2016 by Myriad Genetics for $*****.Here are Danmar Capital's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Aug 03, 2016 | Dec 23, 2014 | Series D | 2265 |
Co-investors of Danmar Capital
Over the past 12 years, 28 investors have co-invested in Danmar Capital's portfolio companies. This includes only funds.
- Invested before Danmar Capital: CincyTech, Mercury Fund and 17 others have invested in rounds before Danmar Capital. There are 2 companies where CincyTech has invested before Danmar Capital and 1 company where Mercury Fund has invested before Danmar Capital.
- Top Co-investors of Danmar Capital: 5 investors entered a company along with Danmar Capital. These include investors like Synchrony (1 company).
- Invested after Danmar Capital: A total of 4 investors have invested in Danmar Capital's portfolio after their investments. Top Investors include Visa (1 company), Mastercard (1 company) and Ntt Docomo Ventures (1 company).
